Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously renew...
Source And Potency Of Stem Cells01:27

Source And Potency Of Stem Cells

Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Stem Cell Niche01:26

Stem Cell Niche

The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perspectives of advanced practitioner students on reliability and validity of objective structured clinical examinations.

British journal of nursing (Mark Allen Publishing)·2026
Same author

Intraoperative Peripheral Iridotomy for Endothelial Keratoplasty with a 22-Gauge Needle.

Eye banking and corneal transplantation·2026
Same author

Spondylolysis: A Narrative Review of Etiology, Diagnosis, and Management.

International journal of environmental research and public health·2026
Same author

Evaluating OSCE assessments in UK advanced practice curricula: insights from educators.

British journal of nursing (Mark Allen Publishing)·2026
Same author

Associations Between Visual Impairment and Homebound Status, Home Hazards, and Support Service Utilization: The National Health and Aging Trends Study.

American journal of ophthalmology·2025
Same author

Opsoclonus-Myoclonus-Ataxia Syndrome in a Patient With West Nile Virus: Case Report and a Patient's Experience.

The Neurohospitalist·2025

Related Experiment Video

Updated: May 28, 2026

Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies
12:38

Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies

Published on: July 19, 2007

California: 'the Stem Cell State'. Interview with Jonathan Thomas.

Jonathan Thomas

    Regenerative Medicine
    |October 18, 2011
    PubMed
    Summary
    This summary is machine-generated.

    Jonathan Thomas, new Chairman of the California Institute for Regenerative Medicine (CIRM), outlines key goals for regenerative medicine. He emphasizes the critical role of patient advocates in the institute's future.

    More Related Videos

    Electrically Conductive Scaffold to Modulate and Deliver Stem Cells
    05:49

    Electrically Conductive Scaffold to Modulate and Deliver Stem Cells

    Published on: April 13, 2018

    Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research
    08:06

    Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

    Published on: May 21, 2008

    Related Experiment Videos

    Last Updated: May 28, 2026

    Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies
    12:38

    Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies

    Published on: July 19, 2007

    Electrically Conductive Scaffold to Modulate and Deliver Stem Cells
    05:49

    Electrically Conductive Scaffold to Modulate and Deliver Stem Cells

    Published on: April 13, 2018

    Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research
    08:06

    Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

    Published on: May 21, 2008

    Area of Science:

    • Regenerative Medicine
    • Biotechnology
    • Healthcare Policy

    Background:

    • Jonathan Thomas assumed leadership of the California Institute for Regenerative Medicine (CIRM) in June 2011.
    • Thomas brings a background in finance, law, and biological sciences to his role.
    • His interest in patient advocacy and biology influenced his decision to lead CIRM.

    Discussion:

    • The interview focuses on Thomas's vision for CIRM's strategic objectives.
    • Patient advocacy is highlighted as a crucial element for the institute's ongoing success and direction.
    • Thomas's leadership aims to advance regenerative medicine research and therapies.

    Key Insights:

    • CIRM's future direction under new leadership.
    • The integral role of patient perspectives in shaping regenerative medicine initiatives.
    • Leveraging diverse expertise for scientific and financial oversight.

    Outlook:

    • Continued advancement of stem cell therapies and regenerative medicine.
    • Strengthening the partnership between researchers, patients, and funding bodies.
    • Ensuring CIRM's continued impact on therapeutic development and patient care.